Sarepta Therapeutics, Inc. (SRPT)

NASDAQ: SRPT · Real-Time Price · USD
17.46
-1.52 (-8.01%)
At close: Jun 25, 2025, 4:00 PM
17.69
+0.23 (1.31%)
After-hours: Jun 25, 2025, 7:58 PM EDT

Sarepta Therapeutics Stock Forecast

Stock Price Forecast

The 25 analysts that cover Sarepta Therapeutics stock have a consensus rating of "Buy" and an average price target of $64, which forecasts a 266.55% increase in the stock price over the next year. The lowest target is $10 and the highest is $170.

Price Target: $64 (+266.55%)
Analyst Consensus: Buy
Target Low Average Median High
Price $10 $64 $50 $170
Change -42.73% +266.55% +186.37% +873.65%

Analyst Ratings

The average analyst rating for Sarepta Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jan '25Feb '25Mar '25Apr '25May '25Jun '25
Strong Buy 665564
Buy 131211121210
Hold 1134510
Sell 000000
Strong Sell 222101
Total 222121222325

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Sell
Downgrades
$40$10
Strong Sell Downgrades $40$10 -42.73% Jun 25, 2025
Oppenheimer
Oppenheimer
Buy
Maintains
$123$45
Buy Maintains $123$45 +157.73% Jun 20, 2025
William Blair
William Blair
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Jun 20, 2025
Mizuho
Mizuho
Buy
Maintains
$85$40
Buy Maintains $85$40 +129.10% Jun 18, 2025
Deutsche Bank
Deutsche Bank
Hold
Maintains
$50$25
Hold Maintains $50$25 +43.18% Jun 17, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
2.41B
from 1.90B
Increased by 26.87%
Revenue Next Year
2.49B
from 2.41B
Increased by 3.15%
EPS This Year
-2.57
from 2.34
EPS Next Year
4.70
from -2.57
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
540.10M701.89M933.01M1.24B1.90B2.41B2.49B2.60B
Revenue Growth
41.82%29.96%32.93%33.26%52.97%26.87%3.15%4.58%
EPS
-7.11-5.15-8.03-5.802.34-2.574.705.88
EPS Growth
-------25.25%
Forward PE
------3.722.97
No. Analysts
-----292816
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 3.0B 3.9B 4.0B
Avg 2.4B 2.5B 2.6B
Low 2.0B 1.1B 1.3B

Revenue Growth

Revenue Growth 20252026202720282029
High
55.8%
63.2%
59.7%
Avg
26.9%
3.1%
4.6%
Low
2.6%
-52.7%
-47.0%

EPS Forecast

EPS 20252026202720282029
High 0.98 14.18 15.27
Avg -2.57 4.70 5.88
Low -5.76 -2.12 -0.46

EPS Growth

EPS Growth 20252026202720282029
High
-58.2%
-
225.1%
Avg - -
25.2%
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.